Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin in Severe Traumatic Brain Injury
NCT00313716Phase 3Completed
- Start
- Apr 2006
- Primary completion
- Mar 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of erythropoietin in traumatic brain injury (TBI) and anemia. Started Apr 2006; status: completed.
02
Drugs
erythropoietin
03
Conditions
traumatic brain injury (TBI)anemia
Beyond the preview
Go deeper on NCT00313716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00313716.